Sign in
4

Changes in Ownership

Coherus Oncology, Inc. Filed Acc 0000899243-16-015772

Options or other derivatives

  • Director bought 0 shares

From the SEC's structured data for this filing

Trades in this filing

Wahlstrom Mats · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-02-29 Purchase : show line 1 in the form 8.2% Senior Convertible Notes due 2022 +0 $22.35 $0 I
Loading xslF345X03/doc4.xml…